CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: mefenamic acid
Accession: CHEBI:6717
browse the term
Definition: An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis.
Synonyms: exact_synonym: 2-[(2,3-dimethylphenyl)amino]benzoic acid
related_synonym: CI-473; CN-35355; Formula=C15H15NO2; INF-3355; InChI=1S/C15H15NO2/c1-10-6-5-9-13(11(10)2)16-14-8-4-3-7-12(14)15(17)18/h3-9,16H,1-2H3,(H,17,18); InChIKey=HYYBABOKPJLUIN-UHFFFAOYSA-N; Mefenaminsaeure; N-(2,3-xylyl)-2-aminobenzoic acid; N-2,3-xylylanthranilic acid; Ponstel; SMILES=Cc1cccc(Nc2ccccc2C(O)=O)c1C; acide mefenamique; acido mefenamico; acidum mefenamicum
xref: CAS:61-68-7; DrugBank:DB00784; Drug_Central:1663; HMDB:HMDB0014922; KEGG:C02168; KEGG:D00151; LINCS:LSM-4085
xref_mesh: MESH:D008528
xref: PDBeChem:ID8; PMID:14001132; PMID:17330662; PMID:22275128; PMID:22369458; PMID:23402341; PMID:23494912; PMID:23656341; PMID:2684858; PMID:28166217; PMID:3304401; PMID:4212650; PMID:425903; PMID:4916242; PMID:5286553; PMID:577447; PMID:6155061; Patent:BE605302; Patent:US3138636; Reaxys:2216243; Wikipedia:Mefenamic_acid
G
Akr1c1
aldo-keto reductase family 1, member C1
decreases activity
ISO
Mefenamic Acid analog results in decreased activity of AKR1C1 protein
CTD
PMID:19010312
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
G
Akr1c2
aldo-keto reductase family 1, member C2
decreases activity
ISO
Mefenamic Acid analog results in decreased activity of AKR1C2 protein
CTD
PMID:19010312
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
G
Akr1c3
aldo-keto reductase family 1, member C3
decreases activity
ISO
Mefenamic Acid analog results in decreased activity of AKR1C3 protein
CTD
PMID:19010312
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
G
Alb
albumin
multiple interactions affects binding
ISO
Mefenamic Acid inhibits the reaction [Valproic Acid binds to ALB protein] Mefenamic Acid binds to ALB protein
CTD
PMID:8946661
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases glutathionylation increases hydroxylation
ISO
CYP1A1 protein results in increased glutathionylation of Mefenamic Acid analog CYP1A1 protein results in increased hydroxylation of Mefenamic Acid
CTD
PMID:25372302
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
decreases activity increases glutathionylation increases hydroxylation multiple interactions increases oxidation
ISO
Mefenamic Acid results in decreased activity of CYP1A2 protein CYP1A2 protein results in increased glutathionylation of Mefenamic Acid analog CYP1A2 protein results in increased hydroxylation of Mefenamic Acid SOD1 protein inhibits the reaction [CYP1A2 protein results in increased oxidation of Mefenamic Acid]
CTD
PMID:18816299 PMID:25372302 PMID:33259822
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
decreases activity
ISO
Mefenamic Acid results in decreased activity of CYP1B1 protein
CTD
PMID:33814510
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp2c6v1
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1
increases hydroxylation
ISO
CYP2C19 protein results in increased hydroxylation of Mefenamic Acid
CTD
PMID:25372302
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases hydroxylation increases glutathionylation
ISO
CYP3A4 protein results in increased hydroxylation of Mefenamic Acid CYP3A4 protein results in increased glutathionylation of Mefenamic Acid analog
CTD
PMID:25372302
NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008
G
Gsta1
glutathione S-transferase alpha 1
increases glutathionylation
ISO
GSTA1 protein results in increased glutathionylation of Mefenamic Acid analog
CTD
PMID:25372302
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
G
Gsta2
glutathione S-transferase alpha 2
increases glutathionylation
ISO
GSTA2 protein results in increased glutathionylation of Mefenamic Acid analog
CTD
PMID:25372302
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
G
Gstm1
glutathione S-transferase mu 1
increases glutathionylation
ISO
GSTM1 protein results in increased glutathionylation of Mefenamic Acid analog
CTD
PMID:25372302
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstm5
glutathione S-transferase, mu 5
increases glutathionylation
ISO
GSTM3 protein results in increased glutathionylation of Mefenamic Acid analog
CTD
PMID:25372302
NCBI chr 2:195,531,627...195,534,562
Ensembl chr 2:195,531,495...195,534,553
G
Gstp1
glutathione S-transferase pi 1
increases glutathionylation
ISO
GSTP1 protein results in increased glutathionylation of Mefenamic Acid analog
CTD
PMID:25372302
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Hpgd
15-hydroxyprostaglandin dehydrogenase
increases activity increases expression
ISO
Mefenamic Acid results in increased activity of HPGD protein Mefenamic Acid results in increased expression of HPGD mRNA
CTD
PMID:19501039
NCBI chr16:33,986,265...34,024,228
Ensembl chr16:33,986,266...34,024,228
G
Il1b
interleukin 1 beta
decreases secretion
ISO
Mefenamic Acid results in decreased secretion of IL1B protein
CTD
PMID:10393680
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
decreases secretion
ISO
Mefenamic Acid results in decreased secretion of IL6 protein
CTD
PMID:10393680
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Kcnk10
potassium two pore domain channel subfamily K member 10
multiple interactions
ISO
Mefenamic Acid promotes the reaction [KCNK10 protein results in increased transport of Potassium]
CTD
PMID:16075240
NCBI chr 6:117,690,052...117,826,120
Ensembl chr 6:117,694,222...117,825,695
G
Kcnk2
potassium two pore domain channel subfamily K member 2
multiple interactions
ISO
Mefenamic Acid promotes the reaction [KCNK2 protein results in increased transport of Potassium]
CTD
PMID:16075240
NCBI chr13:100,766,101...100,963,435
Ensembl chr13:100,766,113...100,963,435
G
Kcnk4
potassium two pore domain channel subfamily K member 4
multiple interactions
ISO
Mefenamic Acid promotes the reaction [KCNK4 protein results in increased transport of Potassium]
CTD
PMID:16075240
NCBI chr 1:204,117,941...204,129,494
Ensembl chr 1:204,114,572...204,125,925
G
Mr1
major histocompatibility complex, class I-related
affects expression
ISO
Mefenamic Acid affects the expression of MR1 mRNA
CTD
PMID:25811541
NCBI chr13:67,298,362...67,317,985
Ensembl chr13:67,299,585...67,317,970
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
ISO
Mefenamic Acid inhibits the reaction [NQO1 protein results in increased reduction of 2,6-Dichloroindophenol]
CTD
PMID:29281794
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nqo2
N-ribosyldihydronicotinamide:quinone reductase 2
multiple interactions
ISO
Mefenamic Acid inhibits the reaction [NQO2 protein results in increased reduction of Vitamin K 3]; NQO2 protein results in increased reduction of and results in decreased glutathionylation of Mefenamic Acid metabolite
CTD
PMID:29281794
NCBI chr17:30,909,482...30,938,725
Ensembl chr17:30,909,187...30,938,320
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases activity
ISO
Mefenamic Acid results in increased activity of NR1I2 protein
CTD
PMID:28728110
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Pon1
paraoxonase 1
multiple interactions
ISO
[pyrrolidine analog binds to Palladium binds to Mefenamic Acid] which results in decreased activity of PON1 protein; [pyrrolidine analog binds to Platinum binds to Mefenamic Acid] which results in decreased activity of PON1 protein
CTD
PMID:29512227
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Sell
selectin L
decreases expression
ISO
Mefenamic Acid results in decreased expression of SELL protein
CTD
PMID:12147693
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
G
Slc22a1
solute carrier family 22 member 1
decreases activity
ISO
Mefenamic Acid results in decreased activity of SLC22A1 protein
CTD
PMID:12388633
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
G
Slc22a25
solute carrier family 22, member 25
decreases activity
ISO
Mefenamic Acid results in decreased activity of SLC22A9 protein
CTD
PMID:12388633
NCBI chr 1:205,338,698...205,498,486
Ensembl chr 1:205,338,699...205,433,085
G
Slc22a6
solute carrier family 22 member 6
decreases activity
ISO
Mefenamic Acid results in decreased activity of SLC22A6 protein
CTD
PMID:12388633
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
G
Slc22a7
solute carrier family 22 member 7
decreases activity
ISO
Mefenamic Acid results in decreased activity of SLC22A7 protein
CTD
PMID:12388633
NCBI chr 9:14,547,073...14,554,354
Ensembl chr 9:14,547,849...14,553,921
G
Sod1
superoxide dismutase 1
multiple interactions
ISO
SOD1 protein inhibits the reaction [CYP1A2 protein results in increased oxidation of Mefenamic Acid]
CTD
PMID:33259822
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sult1a1
sulfotransferase family 1A member 1
multiple interactions decreases activity
ISO EXP
[Mefenamic Acid results in decreased activity of SULT1A1 protein] which results in decreased abundance of 2-amino-1-methyl-6-phenolimidazo(4,5-b)pyridine-DNA adduct; Mefenamic Acid inhibits the reaction [SULT1A1 protein results in increased sulfation of 6-hydroxymelatonin]; Mefenamic Acid inhibits the reaction [SULT1A1 protein results in increased sulfation of Dopamine]; Mefenamic Acid inhibits the reaction [SULT1A1 protein results in increased sulfation of harmol]; Mefenamic Acid inhibits the reaction [SULT1A1 protein results in increased sulfation of naringenin]; Mefenamic Acid inhibits the reaction [SULT1A1 protein results in increased sulfation of salicylamide]
CTD
PMID:11181495 PMID:29596660
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
G
Tyr
tyrosinase
decreases expression
ISO
Mefenamic Acid results in decreased expression of TYR mRNA; Mefenamic Acid results in decreased expression of TYR protein
CTD
PMID:21079976
NCBI chr 1:141,115,036...141,210,207
Ensembl chr 1:141,115,036...141,210,207
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
increases glucuronidation
ISO
UGT1A3 protein results in increased glucuronidation of Mefenamic Acid
CTD
PMID:15117964
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt2b7
UDP glucuronosyltransferase family 2 member B7
multiple interactions
ISO
Mefenamic Acid inhibits the reaction [UGT2B7 protein results in increased chemical synthesis of aldosterone 18-glucuronide]; Mefenamic Acid inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Aldosterone]; Mefenamic Acid inhibits the reaction [UGT2B7 protein results in increased metabolism of bromfenac]
CTD
PMID:19740398 PMID:31815452
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all